Education
About Us
Working with TipRanks
Follow Us
Wei-Wu He Insider Profile
11 Followers
Wei-Wu He, Chairman & CEO, Director, Ten Percent Owner at CASI Pharmaceuticals, holds 1.74M shares in CASI Pharmaceuticals (Ticker: CASIF). Most recently, Wei-Wu He Bought 88,154 shares of CASI Pharmaceuticals on Jun 17, 2022 for an estimated value of $272.51K.
Wei-Wu He CASI Pharmaceuticals (CASIF)Chairman & CEO, Director, Ten Percent Owner
CASI Pharmaceuticals (CASIF)
Chairman & CEO, Director, Ten Percent Owner
Ranked #28,581 out of 106,131 Corporate Insiders
Profitable Transactions
6 out of 20 Profitable Transactions
Average Return
+2.80%
Average return per transaction
Time Frame
Compare to
Insider Roles
Chairman & CEO, Director, Ten Percent Owner
Roles that Wei-Wu He holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Sep 20, 2017 - Sep 20, 2018
Return:+214.30%
The most profitable trade made by Wei-Wu He
Wei-Wu He's Trading History
List of latest transactions for each holding click on a transaction to see Wei-Wu He's performance on stock
You May Also Like
Wei-Wu He insider profile FAQ
What is the percentage of profitable transactions made by Wei-Wu He?
The percentage of profitable transactions made by Wei-Wu He is 30%.
What is the average return per transaction made by Wei-Wu He?
The average return per transaction made by Wei-Wu He is 2.80%.
What stocks does Wei-Wu He hold?
Wei-Wu He holds: CASIF stocks.
What was Wei-Wu He’s latest transaction?
Wei-Wu He latest transaction was an Informative Buy of $272.51K.
What was Wei-Wu He's most profitable transaction?
Wei-Wu He’s most profitable transaction was an Informative Buy of CASIF stock on September 20, 2017. The return on the trade was 214.30%.
What is Wei-Wu He's role in CASI Pharmaceuticals?
Wei-Wu He's role in CASI Pharmaceuticals is Chairman & CEO, Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.